Citations 1
Outcomes and Attributes Patients Value When Choosing Glucose-Lowering Medications: A Mixed-Methods Study
Bautista, Andrea E. Garcia, Umpierrez, Guillermo E. , Galindo, Rodolfo J. , Brito, Juan P. , Montori, Víctor M. , Gockerman, Janet P., Tesulov, Michael, Labatte, Bertina, Mickelson, Mindy M. , Golembiewski, Elizabeth H , Garcia Bautista, Andrea E, Umpierrez, Guillermo E. , Galindo, Rodolfo J , Montori, Victor M , McCoy, Rozalina Grubina , Brito, Juan P , Golembiewski, Elizabeth H. , Polley, Eric C. , Tesulov, Michael, Labatte, Bertina, Mickelson, Mindy M , McCoy, Rozalina G.
Clinical Diabetes | January 22, 2024 | Volume: 42 | Issue: 3 | Pages: 371-387
This mixed-methods study sought to identify pharmacotherapy preferences among 40 noninsulin-treated adults with type 2 diabetes receiving care at two U.S. health care systems. Participants ranked by relative importance various health outcomes and medication attributes and then contextualized their rankings. Most participants ranked blindness (63%), death (60%), heart attack (48%), and heart failure (48%) as the most important health outcomes and glucose-lowering efficacy (68%) as the most important medication attribute, followed by oral administration (45%) and lack of gastrointestinal side effects (38%).